Nurse Alternative-to-Discipline Programs: Eligibility, Monitoring, and Costs

Nurse alternative-to-discipline programs are confidential monitoring agreements, offered in more than 40 states, that let a nurse with a substance use disorder or certain mental health conditions keep practicing under heavy restrictions instead of facing suspension or revocation. They typically run three to five years, require random drug testing and support group attendance, and carry a roughly 61.5% completion rate across participants nationally.¹ The trade-off is real: you keep your license, but you give up appeal rights, pay thousands out of pocket, and accept restrictions that will reshape what nursing work is available to you for years.

Who Qualifies

Eligibility starts with a clinical screening that confirms a diagnosed substance use disorder and determines whether you’re appropriate for monitoring rather than discipline.² Timing matters more than almost anything else. Self-reporting before a formal complaint or investigation dramatically improves your chances of being offered the alternative track. Once a board investigation is underway, the traditional disciplinary process has momentum, and convincing the board to divert the case becomes much harder.

Several categories of conduct disqualify you outright. Under NCSBN guidelines, a nurse cannot enter an alternative program if they diverted drugs for sale or distribution, caused patient harm because of their substance use, or engaged in conduct with a high potential to cause harm, such as replacing a patient’s medication with a placebo.² Sexual misconduct involving patients and workplace financial crimes like embezzlement also result in denial. A nurse who previously failed an alternative program is unlikely to be offered a second chance through the same pathway.

The line between personal use and distribution is critical. A nurse who took medications from the facility’s supply for their own consumption may still qualify. A nurse who sold or distributed those drugs will not. Boards draw this line because the programs are designed around recovery from a health condition, not rehabilitation from commercial drug trafficking.

What You Agree To When You Sign

Enrollment runs through a board-approved clinical evaluation, a written self-report of the events that brought you in, a list of your current treatment providers, and signed consents allowing those providers to share progress reports with the monitoring agency. The application package goes to your state’s board of nursing or its designated third-party program administrator. After an intake interview, you’ll receive an individualized monitoring contract specifying evaluation and treatment requirements, drug screening protocols, worksite limitations, and compliance reporting obligations.

Read the contract carefully before signing. Entering the program requires admitting to problems with substance use and waiving all rights to appeal, file grievances, or contest licensing actions that arise from the program.² That waiver is not a formality. Once you’re enrolled, the board holds all the leverage, and any dispute over whether you’ve met your contract terms will not go through the ordinary administrative hearing process.

What the Monitoring Looks Like

The core obligations are drug testing, support group attendance, regular check-ins with the monitoring program, and treatment compliance.

Drug testing is random and happens at least twice per month, using varying methods such as urine, hair, or nail testing.¹ Tests follow strict chain-of-custody protocols, and you’re responsible for getting to the collection site when called, often on short notice. Structured support group meetings led by a facilitator run at least twice per month, and mutual support meetings such as AA or NA happen at least once per week. Daily check-ins with the monitoring program round out the compliance picture.

Reporting obligations extend well past testing. Prescriptions for any mood-altering medication, and in many contracts over-the-counter drugs, must be disclosed immediately. Criminal arrests or citations, changes in employment, and terminations or disciplinary meetings with your employer all carry tight reporting windows. Failing to report any of these counts as a noncompliance event, which accumulates on your record and can trigger contract modifications or termination.

What You Can and Cannot Do at Work

Practice restrictions are the most disruptive part of the program for most participants. About 85% of programs impose them.³ The specifics vary by jurisdiction and individual contract, but the common ones include:

No access to controlled substances for a significant portion of your monitoring period. There is no universal standard for how long this lasts; it’s set based on your progress and the nature of your substance use.
No work through staffing agencies, travel nursing, private duty, float pools, or home health, because those settings lack the direct oversight your contract requires.
No supervisory role over other nurses, and often not over other licensed or unlicensed staff either.
No teaching in a nursing program or as a continuing education instructor.
No working more than 40 hours per week without board approval and documentation.

The controlled substance restriction is the one participants most often cite as the biggest barrier to returning to work, because so many nursing positions require narcotic administration. Employers willing to accommodate exist, but finding them takes effort, and the roles and shifts available to you may shrink considerably during the first year or two.

What It Costs

Every cost falls on you. There is no evidence of financial support programs or subsidies for participants in any state.⁴ Expect the following ranges:

Monthly monitoring fees: $0 to $175.
Initial clinical evaluation: $0 to $1,500.
Inpatient treatment, if required: around $6,000 per month.
Intensive outpatient treatment, if required: around $5,000 for a three-month program.
Individual counseling: $100 to $200 per session.
Group therapy: $0 to $40 per week.
Drug screening: $35 to $100 per test, with at least 24 tests per year.

Over a three-to-five-year monitoring period, the total out-of-pocket cost can reach tens of thousands of dollars, before you count lost income from reduced hours, transportation to testing sites, and childcare. Longer monitoring periods consistently produce better outcomes, but they also cost more.⁴

What It Does to Your License Record

Most programs keep participation confidential. The majority do not make participants’ names public, and the terms of your contract are nonpublic, shared only with parties who have an official need to know.² Your license may still carry an encumbered or restricted status during monitoring, which signals to anyone checking that you’re subject to limitations. Successful completion typically removes those restrictions and restores an unencumbered license.

Confidentiality does not mean anonymity at work. You are required to report your participation to your employer, who needs to know about your workplace restrictions and will typically designate a worksite monitor.² If you change jobs during the monitoring period, you’ll disclose to the new employer as well.

National Practitioner Data Bank

Whether your participation gets reported to the NPDB depends entirely on whether your board takes a formal action. If you voluntarily enter a program and the board does not issue any order restricting your practice, no NPDB report is filed, and the fact that you entered treatment should not itself be reported.⁵ An enforceable agreement not to practice, even one framed as voluntary, is reportable. Placing your license in inactive status while under investigation, or voluntarily surrendering it to avoid an investigation, also triggers a report. NPDB reports follow you permanently, so if you have any choice in how your entry into the program is structured, understanding whether the arrangement triggers a report should be your first question.

Multistate License Under the Compact

If you hold a multistate license through the Nurse Licensure Compact, which now covers 43 jurisdictions, your multistate privilege is affected immediately.⁶ The NLC’s uniform licensure requirements call for an active, unencumbered license to hold multistate privileges, and participation in an alternative-to-discipline program is listed as a disqualifier.⁷ In practice your multistate privilege is deactivated when you enter the program, and you can only practice in your home state under the terms of your monitoring contract. Expect to disclose your participation to any party state where you’ve been practicing.

DEA Registration for Prescribing Nurses

Advanced practice registered nurses with prescriptive authority face an additional layer. If your state board restricts or suspends your license, the DEA has authority to suspend or revoke your controlled substance registration under federal law.⁸ Even without independent DEA action, many monitoring contracts require you to surrender your DEA registration or restrict your prescribing to non-controlled medications for the duration of the program. The DEA will later consider your state board’s recommendation when evaluating any future registration application.⁹

One distinction deserves close attention: surrendering a DEA registration “for cause,” meaning you gave it up to avoid or as a result of an investigation, creates a permanent employment barrier. Federal regulations prohibit any practitioner from employing someone who surrendered a registration for cause in a position with access to controlled substances. If you surrender your registration as part of a monitoring agreement, confirm in writing whether that surrender is classified as “for cause.”

Relapse and Non-Compliance

The research is blunt: a relapse at any point during the program is strongly associated with failing to complete it. Among 7,737 nurses studied, 64.7% of those with no relapses finished the program, compared to only 35.4% of those who relapsed even once.¹ The recommended threshold is zero positive drug tests and zero relapses.

A single relapse doesn’t necessarily end the program. Resetting the monitoring period after a relapse can still produce successful outcomes, particularly with continued twice-monthly testing and two to three years of additional monitoring. The practical consequence of a first relapse is usually a contract modification, meaning extended monitoring, increased testing, and additional treatment requirements, rather than immediate termination.

Non-compliance covers more than positive tests. Late reports, missed check-ins, no-shows for testing, and failure to disclose required events all count. Accumulated noncompliance can escalate to discharge from the program, at which point the case reverts to the board’s standard disciplinary process and whatever confidentiality you had is gone. Noncompliance can also result in a cease-to-practice order, notification of your employer, extension of your contract, a report to the board of nursing, or automatic public discipline. Once a formal disciplinary order issues, it is reported to national databanks including NURSYS and the NPDB and becomes a permanent part of your professional record.²

Completion Odds and What Success Looks Like

Approximately 61.5% of nurses nationally complete monitoring successfully, with individual program completion rates ranging from about 52% to 88%. The factors most strongly correlated with success are straightforward: staying enrolled for at least three years, being tested at least twice monthly, attending mutual support meetings weekly, and checking in with the monitoring program daily.¹ Completion rates peak around the five-year mark.

Successful completion typically results in the removal of all license restrictions, restoration of full unencumbered status, and, if your state treated the program as confidential, no permanent public record of the monitoring period. APRNs who surrendered a DEA registration will need to apply for a new one, with the state board’s recommendation factored into that process. The 38.5% who don’t finish face worse outcomes than if they’d gone through standard discipline from the start, because they’ve waived their appeal rights and accumulated a documented record of noncompliance that the board can use against them.

1
National Council of State Boards of Nursing. Outcomes of Substance Use Disorder Monitoring Programs for Nurses
2
National Council of State Boards of Nursing. Substance Use Disorders and Accessing Alternative-to-Discipline Programs
3
National Library of Medicine. Are Alternative to Discipline Programs for Nurses With Alcohol and Other Drug Challenges Relevant to Global Contexts? A Scoping Review
4
OJIN: The Online Journal of Issues in Nursing. Accessibility and Financial Barriers in the Utilization of Alternative to Discipline Programs in the United States
5
NPDB. Reports, Reporting State Licensure and Certification Actions
6
Nurse Licensure Compact. Frequently Asked Questions
7
National Council of State Boards of Nursing. Uniform Licensure Requirements for a Multistate License
8
Office of the Law Revision Counsel. 21 USC 824 – Denial, Revocation, or Suspension of Registration
9
Office of the Law Revision Counsel. 21 USC 823 – Registration Requirements